| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.24 | 5e-12 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |